This was the stock's third consecutive day of losses.

CVS Health shows strong growth with strategic shifts, improved Medicare ratings, and promising earnings. Read why I see CVS ...

The stock's fall snapped a two-day winning streak.

Eli Lilly and Company's stock dropped 11% after CVS's Zepbound exclusion, but analysts see a mispricing opportunity. Click ...

Eli Lilly on Thursday downplayed CVS Health's decision to drop the company's obesity drug Zepbound from some lists of ...

We recently published a list of 11 Best Performing Healthcare Stocks to Buy Now. In this article, we are going to take a look at where CVS Health Corporation (NYSE:CVS) stands against other best ...

CVS reported first quarter earnings Thursday, blowing past Wall Street's expectations and ending anxiety over Medicare ...

Eli Lilly (LLY) shares slid at the open despite topping first quarter estimates, with investors reacting to the company ...

CVS Health Corp.’s drug-benefits unit negotiated a deal to make Novo Nordisk A/S’s Wegovy more widely available to its ...

CVS Group has agreed to sell its crematorium ... Britain's veterinary sector has been under investigation by the Competition and Markets Authority amid concerns pet owners are being overcharged.

Eli Lilly on Thursday posted better-than-expected quarterly results, but CVS Health's decision to drop the company's obesity ...

Ambulatory Infusion Center Market report 2025 BURLINGAME, CA, UNITED STATES, May 12, 2025 /EINPresswire / -- The global ambulato ...